Replies to post #38952 on Ayala Pharmaceuticals Inc (ADXS)

[JB-22]

I meant Hans. Here is the meat of the email:

I think their goal was to bring their position below 10% - now it’s done. The pushout on the filing is the result of EMA requesting additional information on OTHER trials that GOG has done in this setting. They asked for the data for comparative purposes. Since the data belong to and are being submitted by GOG, Advaxis has no control over the timing, unfortunately.